Highlights
NASDAQ: CTSO       Cytosorbents Cor
Last Price Today's Change   Day's Range   Trading Volume
9.89   -0.48 (4.63%)  9.84 - 10.50  487,820

Overview

 
Avg Volume (4 weeks):635,700
4 Weeks Range:9.42 - 11.24
4 Weeks Price Volatility (%):
25.82%
52 Weeks Range:3.49 - 11.24
52 Weeks Price Volatility (%):
82.58%
Average Price Target:-

Headlines



No recent Headlines for this stock.


Business Background

CytoSorbents Corp is a critical care immunotherapy company. It investigates and commercializes its blood purification technology to reduce uncontrolled inflammation in hospitalized patients internationally with the goal of preventing and treating multiple organ failure in life-threatening illnesses and cardiac surgery. Its product portfolio consists of Cytosord, Contrastsorb, Vetresq, Hemodefend and Drugsorb. The company's intellectual property consists of composition of matter, materials, methods of production, systems incorporating the technology and multiple medical uses. It derives its revenue from product sales and grants.

  Be the first to like this.
 


APPS
I3 Messenger
Individual or Group chat with anyone on I3investor
 
 

3794  2031  243  2884 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 GNUS 7.93+3.91 
 NIO 5.60+0.90 
 GE 7.36+0.31 
 VISL 0.425+0.086 
 F 6.19+0.29 
 AAL 11.85+0.63 
 UAL 33.65+3.74 
 BAC 25.99+1.15 
 SAVA 3.42+1.38 
 NCLH 17.98+0.59 
Partners & Brokers